Drug Profile
Research programme: monoamine oxidase B inhibitors - Jenrin Discovery
Alternative Names: JD-0100; JD-0200; JD-0300; PS MAO-BLatest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator Jenrin Discovery
- Class Obesity therapies; Small molecules
- Mechanism of Action Monoamine oxidase B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 28 May 2022 No recent reports of development identified for research development in Obesity in USA
- 12 May 2020 Early research is ongoing for Obesity in USA (Jenrin Discovery pipeline, May 2020)
- 16 Jul 2016 No recent reports of development identified for research in Obesity in USA